Starlight Therapeutics
Phase 1Starlight Therapeutic, a wholly owned subsidiary of Lantern Pharma, is advancing STAR-001, an AI-driven treatment for glioblastoma, brain metastases and multiple pediatric CNS cancers. Discover how we’re redefining CNS cancer care today.
Founded
2020
Focus
Small Molecules
About
Starlight Therapeutic, a wholly owned subsidiary of Lantern Pharma, is advancing STAR-001, an AI-driven treatment for glioblastoma, brain metastases and multiple pediatric CNS cancers. Discover how we’re redefining CNS cancer care today.
Company Info
TypePrivate
Founded2020
LocationCambridge, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile